KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $428 | +27.8% | 3,687 | +29.1% | 0.03% | +26.9% |
Q2 2023 | $335 | +20.1% | 2,857 | -18.1% | 0.03% | +30.0% |
Q1 2023 | $279 | +9.0% | 3,488 | +8.1% | 0.02% | -4.8% |
Q4 2022 | $256 | -99.9% | 3,228 | -10.1% | 0.02% | -8.7% |
Q3 2022 | $250,000 | 0.0% | 3,591 | -5.7% | 0.02% | 0.0% |
Q2 2022 | $250,000 | +25.0% | 3,808 | +26.5% | 0.02% | +228.6% |
Q1 2022 | $200,000 | – | 3,011 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 1,095,407 | $71,924,000 | 6.79% |
ACT CAPITAL MANAGEMENT, LLC | 59,000 | $3,874,000 | 5.42% |
S Squared Technology, LLC | 108,215 | $7,105,000 | 4.92% |
Redmile Group, LLC | 1,898,545 | $124,658,000 | 4.76% |
First Light Asset Management, LLC | 595,612 | $39,108,000 | 4.55% |
Soleus Capital Management, L.P. | 214,482 | $14,083,000 | 2.20% |
SILVERARC CAPITAL MANAGEMENT, LLC | 105,277 | $6,912,000 | 2.13% |
Artal Group S.A. | 500,000 | $32,830,000 | 1.75% |
Nicholas Investment Partners, LP | 227,877 | $14,962,000 | 1.41% |
Avoro Capital Advisors LLC | 1,075,000 | $70,585,000 | 1.40% |